Revolutionary approaches to drug discovery aided by informatics and guided toward precision medicine have helped bring new drug approvals back to pre-1996 levels
The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to deliver advanced analytics to underpin scientific decision making
New research finds that chatbots working for reputable organizations can ease the burden on medical providers and offer trusted guidance to those with symptoms
500,000 patient specimens are being collected and tested as an initiative is underway to identify asymptomatic patients while also protecting high-risk population